St Vincent's Institute

St Vincent's Institute SVI is an independent medical research institute focussed on improving the health of all Australians

Diseases studied:
- Cancer and its spread
- Heart Disease
- Type 1 diabetes
- Obesity and type 2 diabetes
- Neurodegenerative diseases
- Osteoporosis
- Mental health disorders (metabolism research)
- Infectious diseases
- Rare diseases

This year’s student-led BioMed Link Conference, held at the Bio21 Institute, brought together around 80 biomedical scien...
01/12/2025

This year’s student-led BioMed Link Conference, held at the Bio21 Institute, brought together around 80 biomedical science students from 15 institutions, creating a vibrant space for connection, collaboration and skill-building across universities.

With presenters representing 15 different disciplines, including strong participation from SVI, the University of Melbourne, Hudson Institute of Medical Research and Murdoch Children's Research Institute (MCRI), the program gave students a rare opportunity to learn from a wide range of scientific fields and from each other.

Find out more about the event: https://www.svi.edu.au/news-events/biomed-link-conference-brings-emerging-researchers-together/

The National Health and Medical Research Council (NHMRC) is highlighting the far-reaching impact of Australian medical r...
26/11/2025

The National Health and Medical Research Council (NHMRC) is highlighting the far-reaching impact of Australian medical research through a new series of case studies.

Among the featured stories is the groundbreaking work in microsurgery led by researchers at SVI's O’Brien Department.

Find out how their development of precision instruments, surgical models and advanced techniques has shaped modern surgical practice around the world: https://www.svi.edu.au/news-events/pioneering-microsurgery-nhmrc-funded-research-leads-to-life-changing-medical-innovations/

SVI had the honour of hosting Professor Sir Philip Cohen, a scientist whose discoveries have shaped modern biology, for ...
18/11/2025

SVI had the honour of hosting Professor Sir Philip Cohen, a scientist whose discoveries have shaped modern biology, for a special seminar this week.

Addressing a full house at the ACMD auditorium, Professor Cohen shared insights into how mutations in the kinase ALPK1 can lead to rare genetic diseases, like ROSAH Syndrome and rare skin tumours called spiradenocarcinomas.

Find out how Professor Cohen’s breakthroughs in cell signalling are guiding new scientific advances: https://www.svi.edu.au/news-events/world-leading-biochemist-sir-philip-cohen-brings-global-expertise-to-svi/

PhD student Kezia Gitareja is studying a new way to stop multiple myeloma, a type of blood cancer that affects the cells...
18/11/2025

PhD student Kezia Gitareja is studying a new way to stop multiple myeloma, a type of blood cancer that affects the cells in our bone marrow.

In a recent study, Kezia showed that certain drugs that target ribosome production kill myeloma cells, even in cases where the disease has come back after treatment.

Now, she’s using advanced tools to find out how these drugs work and how they could be improved for future treatments.

Find out how Kezia is working to shut down cancer's protein factories: https://www.svi.edu.au/news-events/shutting-down-cancers-protein-factories-kezias-search-for-new-multiple-myeloma-treatments/

As we celebrate World Diabetes Day, SVI Director Professor Tom Kay is proud to share how your support is helping give li...
14/11/2025

As we celebrate World Diabetes Day, SVI Director Professor Tom Kay is proud to share how your support is helping give life back to people with diabetes.

Tom and the Immunology team are working towards therapies that protect and restore the body’s natural processes for insulin production and blood glucose management, alongside insulin therapy when needed.

See how their research is reshaping the landscape of diabetes care and prevention: https://www.svi.edu.au/news-events/world-diabetes-day-giving-life-back-to-people-with-diabetes/

Scientists studying the fat-tailed dunnart, a tiny Australian marsupial, have uncovered genetic clues that explain how d...
13/11/2025

Scientists studying the fat-tailed dunnart, a tiny Australian marsupial, have uncovered genetic clues that explain how different mammals develop their facial features.

Marsupials like the dunnart are born extremely early and must quickly develop the muscles and senses needed to crawl into their mother’s pouch, while placental mammals, such as humans and mice, complete most of their development before birth.

The findings offer new insight into how faces evolved across mammals, providing an invaluable reference for future mammalian evolution studies.

Find out more: https://www.svi.edu.au/news-events/from-kangaroos-to-humans-genes-behind-marsupial-faces-offer-clues-to-how-mammals-evolved/

Through her raffle fundraiser, Jedda Hindmarsh is helping to drive awareness, advance scientific discovery, and give hop...
12/11/2025

Through her raffle fundraiser, Jedda Hindmarsh is helping to drive awareness, advance scientific discovery, and give hope to others living with lipoedema.

Every raffle ticket purchased will help fund life-changing research into the chronic and painful condition that affects about 11% of women and remains under-diagnosed.

Find out how Jedda is helping change the future for women with lipoedema: https://www.svi.edu.au/news-events/help-change-the-future-for-women-with-lipoedema/

Building on SVI research from the BANDIT trial, Eli Lilly and Company has announced the launch of the BARICADE Phase 3 t...
07/11/2025

Building on SVI research from the BANDIT trial, Eli Lilly and Company has announced the launch of the BARICADE Phase 3 trials.

This next stage of research will give people living with type 1 diabetes across 20 countries the opportunity to access this promising new therapy.

Professor Thomas Kay led the groundbreaking BANDIT trial at SVI, in which baricitinib preserved pancreatic insulin production in people with newly-diagnosed type 1 diabetes.

Professor John Wentworth, a pioneer of early screening for the disease, is now working to extend these discoveries to people at risk before symptoms appear.

Find out more about the clinical trials: https://www.svi.edu.au/news-events/svi-discovery-leads-to-global-clinical-trials-to-prevent-type-1-diabetes/

Once a champion trainer on the track, Jack Holt became a champion for medical research – a race for cures that continues...
06/11/2025

Once a champion trainer on the track, Jack Holt became a champion for medical research – a race for cures that continues today.

When he died in 1951, he left 200,000 pounds – an enormous sum in those days – to establish a school of medical research at St Vincent’s.

His extraordinary bequest founded what is now SVI, sparking decades of breakthroughs in diabetes, cancer, heart disease and more.

More than 70 years on, his legacy of hope continues to change lives.

Find out more: https://www.svi.edu.au/news-events/the-race-that-never-ends/

SVI is proud to honour the life and legacy of Professor Helen Thomas, whose pioneering research in type 1 diabetes trans...
29/10/2025

SVI is proud to honour the life and legacy of Professor Helen Thomas, whose pioneering research in type 1 diabetes transformed the field.

To commemorate her extraordinary contributions, the Australian Diabetes Society, together with Breakthrough T1D Australia, Diabetes Victoria, and SVI, has announced the establishment of the Helen Thomas Early Career Fellowship in Type 1 Diabetes.

Extending this tribute beyond the lab, SVI has unveiled a new mural dedicated to Helen, created by Melbourne artist Jason Parker.

Find out how this lasting tribute will inspire the next generation of researchers: https://www.svi.edu.au/news-events/a-lasting-tribute-to-professor-helen-thomas-inspiring-the-next-generation-of-diabetes-researchers/

SVI paid tribute to more than three decades of extraordinary dedication from its SVI Support Group, marking a milestone ...
21/10/2025

SVI paid tribute to more than three decades of extraordinary dedication from its SVI Support Group, marking a milestone moment in the Institute’s history.

At a heartfelt gathering attended by past and present members, students, and staff, the Institute acknowledged the Group’s invaluable contribution to advancing medical research and supporting emerging scientific talent.

Find out more about the Support Group Committee's legacy: https://www.svi.edu.au/news-events/a-thirty-five-year-legacy-of-impact-and-generosity/

Address

9 Princes Street
Melbourne, VIC
3065

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+61392312391

Website

Alerts

Be the first to know and let us send you an email when St Vincent's Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to St Vincent's Institute:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Diseases studied: - Cancer - Type 1 diabetes - Obesity and type 2 diabetes - Alzheimer's disease - Bone diseases such as arthritis and osteoporosis - Heart disease - Infectious diseases